News
Vanda reports positive data of tasimelteon in Non-24-Hour Disorder
Vanda Pharmaceuticals' tasimelteon has shown the ability to reset the body clock and to align it to a constant 24-hour day in patients suffering...
News
Prosensa secures financing to develop RNA-modulating therapeutics
Dutch-based biopharmaceutical company, Prosensa has raised €23m in new equity financing to advance its portfolio of RNA-modulating therapeutics for the treatment of rare diseases,...
News
Selventa receives new patent for discovery of biomarker profiles
Selventa, a biomarker discovery company, has received US patent entitled Computer-aided Discovery of Biomarker Profiles in Complex Biological Systems. The patent is...
News
Upsher-Smith launches new prenatal vitamin
Upsher-Smith Laboratories has launched B-Nexa, a prescription prenatal vitamin for pregnant women who suffer from nausea and vomiting of pregnancy (NVP). ...
News
Merck will pay a maximum of $37 million to...
The settlement includes $10 million in costs and fees, and will total between $21.8 million and $37 million, depending upon the number of eligible claims....
News
BTG receives US Voraxaze approval
UK-based pharmaceutical company BTG has received US Food and Drug Adminsitration (FDA) approval for its Voraxaze medication, which is used to treat patients suffering from toxic...
News
AstraZeneca and Bristol-Myers Squibb diabetes drug rejected by FDA
Approval for AstraZeneca and Bristol-Myers Squibb's diabetes drug dapagliflozin has been rejected by the US Food and Drug Administration. The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.